XRCC4 and cervical carcinoma: Takada et al. [16] have shown that a low expression of Ku86 and XRCC4, proteins involved in the NHEJ pathway, correlates with a better rate of complete remission in patients with cervical cancer treated with preoperative radiotherapy.